1Pirsch JD, Miller J, Deierhor MH, et al.A comparison of tacrolimus(FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation, 1997,63 : 977.
2Sander M,Lyson T,Thomas GD, et al . Sympathetic neural mechanisms of cyclosporine induced hypertension. Am J Hypertens1996, 9(S) : 121.
3Haas M, Mayer G. Cyclosporin A-associated hypertension-pathomechanisms and clinical consequences. Nephrol Dial Transplant, 1997,12:395.
4Taler SJ,Textor SC, Canzanello VJ, et al. Cyclosporine induced hypertension: Incidence, pathogenesis and management. Drug Saf, 1999,20:437.
5Shin GT, Khanna A, Ding R, et al. In vivo expression of transforming growth factor-betal in humans: stimulation by cyclosporine. Transplantation . 1998.65:313.
6Boots JMM, Christiaans M HL, van Duijnhoven EM, et al. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study . Transplantation , 2002,74: 1 703.
7Vincenti F, Jensik SC, Filo RS, et al.A Long-term comparison of tacrolimus(FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation, 2002, 73:775.
8Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: A randomized multicentre study, lancet, 2002,359: 741.
9Friemann S,Stopp K, Christ B, et al . Conversion to tacrolimus in hyperlipidemic patients.Transplant Proc, 1999,31 (S) :41.
